{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:54:52Z","timestamp":1789779292154,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,24]]},"DOI":"10.7759\/cureus.84726","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T09:50:17Z","timestamp":1748080217000},"source":"Crossref","is-referenced-by-count":2,"title":["Investigating the Role of Nandrolone Decanoate in the Management of Osteosarcopenia in Postmenopausal Women: A Prospective Observational Study"],"prefix":"10.7759","author":[{"given":"Bharat","family":"Dave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandesh","family":"Agarawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivanand","family":"Mayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi R","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirant B","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijith","family":"Anil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/127.5.990S","article-title":"Sarcopenia: origins and clinical relevance","volume":"127","author":"Rosenberg IH","year":"1997","unstructured":"Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997, 127:990S-1S. 10.1093\/jn\/127.5.990S","journal-title":"J Nutr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-012-0089-z","article-title":"From muscle wasting to sarcopenia and myopenia: update 2012","volume":"3","author":"von Haehling S","year":"2012","unstructured":"von Haehling S, Morley JE, Anker SD. From muscle wasting to sarcopenia and myopenia: update 2012. J Cachexia Sarcopenia Muscle. 2012, 3:213-7. 10.1007\/s13539-012-0089-z","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1780-5","article-title":"Assessment of fracture risk","volume":"16","author":"Kanis JA","year":"2005","unstructured":"Kanis JA, Borgstrom F, De Laet C, et al.. Assessment of fracture risk. Osteoporos Int. 2005, 16:581-9. 10.1007\/s00198-004-1780-5","journal-title":"Osteoporos Int"},{"key":"ref4","article-title":"Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis: Report of a WHO Study Group [Meeting Held in Rome From 22 to 25 June 1992]","author":"World Health Organization","year":"1994","unstructured":"World Health Organization. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis: Report of a WHO Study Group [Meeting Held in Rome From 22 to 25 June 1992]. World Health Organization, 1994."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-018-0079-6","article-title":"Sarcopenia and osteoporosis in older people: a systematic review and meta-analysis","volume":"9","author":"Nielsen BR","year":"2018","unstructured":"Nielsen BR, Abdulla J, Andersen HE, Schwarz P, Suetta C. Sarcopenia and osteoporosis in older people: a systematic review and meta-analysis. Eur Geriatr Med. 2018, 9:419-34. 10.1007\/s41999-018-0079-6","journal-title":"Eur Geriatr Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Cruz-Jentoft AJ","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al.. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010, 39:412-23. 10.1093\/ageing\/afq034","journal-title":"Age Ageing"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-016-0704-5","article-title":"Sarcopenia: an overview","volume":"29","author":"Marzetti E","year":"2017","unstructured":"Marzetti E, Calvani R, Tosato M, et al.. Sarcopenia: an overview. Aging Clin Exp Res. 2017, 29:11-7. 10.1007\/s40520-016-0704-5","journal-title":"Aging Clin Exp Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2018.79.5.253","article-title":"Osteosarcopenia","volume":"79","author":"Paintin J","year":"2018","unstructured":"Paintin J, Cooper C, Dennison E. Osteosarcopenia. Br J Hosp Med (Lond). 2018, 79:253-8. 10.12968\/hmed.2018.79.5.253","journal-title":"Br J Hosp Med (Lond)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-021-01968-y","article-title":"Osteosarcopenia, the co-existence of osteoporosis and sarcopenia, is associated with social frailty in older adults","volume":"34","author":"Inoue T","year":"2022","unstructured":"Inoue T, Maeda K, Satake S, Matsui Y, Arai H. Osteosarcopenia, the co-existence of osteoporosis and sarcopenia, is associated with social frailty in older adults. Aging Clin Exp Res. 2022, 34:535-43. 10.1007\/s40520-021-01968-y","journal-title":"Aging Clin Exp Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/pl00010639","article-title":"The effects of nandrolone decanoate on bone mass and metabolism in ovariectomized rats with osteopenia","volume":"18","author":"Li X","year":"2000","unstructured":"Li X, Takahashi M, Kushida K, Shimizu S, Hoshino H, Suzuki M, Inoue T. The effects of nandrolone decanoate on bone mass and metabolism in ovariectomized rats with osteopenia. J Bone Miner Metab. 2000, 18:258-63. 10.1007\/pl00010639","journal-title":"J Bone Miner Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2023.112106","article-title":"Using minimal clinically important differences to measure long-term transitions of osteosarcopenia: the New Mexico Aging Process Study","volume":"173","author":"Vlietstra L","year":"2023","unstructured":"Vlietstra L, Kirk B, Duque G, et al.. Using minimal clinically important differences to measure long-term transitions of osteosarcopenia: the New Mexico Aging Process Study. Exp Gerontol. 2023, 173:112106. 10.1016\/j.exger.2023.112106","journal-title":"Exp Gerontol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-009-1070-1","article-title":"What is an acceptable outcome of treatment before it begins? Methodological considerations and implications for patients with chronic low back pain","volume":"18","author":"Lauridsen HH","year":"2009","unstructured":"Lauridsen HH, Manniche C, Korsholm L, Grunnet-Nilsson N, Hartvigsen J. What is an acceptable outcome of treatment before it begins? Methodological considerations and implications for patients with chronic low back pain. Eur Spine J. 2009, 18:1858-66. 10.1007\/s00586-009-1070-1","journal-title":"Eur Spine J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-1-60","article-title":"The Quality of Life Scale (QOLS): reliability, validity, and utilization","volume":"1","author":"Burckhardt CS","year":"2003","unstructured":"Burckhardt CS, Anderson KL. The Quality of Life Scale (QOLS): reliability, validity, and utilization. Health Qual Life Outcomes. 2003, 1:60. 10.1186\/1477-7525-1-60","journal-title":"Health Qual Life Outcomes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/60.5.648","article-title":"The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial","volume":"60","author":"Frisoli A Jr","year":"2005","unstructured":"Frisoli A Jr, Chaves PH, Pinheiro MM, Szejnfeld VL. The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial. J Gerontol A Biol Sci Med Sci. 2005, 60:648-53. 10.1093\/gerona\/60.5.648","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(89)90081-4","article-title":"Changes in soft tissue body composition and plasma lipid metabolism during nandrolone decanoate therapy in postmenopausal osteoporotic women","volume":"38","author":"Hassager C","year":"1989","unstructured":"Hassager C, P\u00f8denphant J, Riis BJ, Johansen JS, Jensen J, Christiansen C. Changes in soft tissue body composition and plasma lipid metabolism during nandrolone decanoate therapy in postmenopausal osteoporotic women. Metabolism. 1989, 38:238-42. 10.1016\/0026-0495(89)90081-4","journal-title":"Metabolism"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.14.1275","article-title":"Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial","volume":"281","author":"Johansen KL","year":"1999","unstructured":"Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA. 1999, 281:1275-81. 10.1001\/jama.281.14.1275","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/BF01623456","article-title":"Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis","volume":"7","author":"Flicker L","year":"1997","unstructured":"Flicker L, Hopper JL, Larkins RG, Lichtenstein M, Buirski G, Wark JD. Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis. Osteoporos Int. 1997, 7:29-35. 10.1007\/BF01623456","journal-title":"Osteoporos Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12369","article-title":"Osteoporosis: the evolution of a diagnosis","volume":"277","author":"Lorentzon M","year":"2015","unstructured":"Lorentzon M, Cummings SR. Osteoporosis: the evolution of a diagnosis. J Intern Med. 2015, 277:650-61. 10.1111\/joim.12369","journal-title":"J Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-013-2427-1","article-title":"What\u2019s in a name revisited: should osteoporosis and sarcopenia be considered components of \u201cdysmobility syndrome?\u201d","volume":"24","author":"Binkley N","year":"2013","unstructured":"Binkley N, Krueger D, Buehring B. What\u2019s in a name revisited: should osteoporosis and sarcopenia be considered components of \u201cdysmobility syndrome?\u201d. Osteoporos Int. 2013, 24:2955-9. 10.1007\/s00198-013-2427-1","journal-title":"Osteoporos Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa755","article-title":"Osteosarcopenia: where osteoporosis and sarcopenia collide","volume":"60","author":"Clynes MA","year":"2021","unstructured":"Clynes MA, Gregson CL, Bruy\u00e8re O, Cooper C, Dennison EM. Osteosarcopenia: where osteoporosis and sarcopenia collide. Rheumatology (Oxford). 2021, 60:529-37. 10.1093\/rheumatology\/keaa755","journal-title":"Rheumatology (Oxford)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000867","article-title":"The use of anabolic agents in the treatment of osteoporosis: a clinical update","volume":"31","author":"Inderjeeth CA","year":"2024","unstructured":"Inderjeeth CA, Inderjeeth DC. The use of anabolic agents in the treatment of osteoporosis: a clinical update. Curr Opin Endocrinol Diabetes Obes. 2024, 31:157-63. 10.1097\/MED.0000000000000867","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12569","article-title":"The roles of sex hormones in the pathophysiology of age-related sarcopenia and frailty","volume":"23","author":"Hosoi T","year":"2024","unstructured":"Hosoi T, Yakabe M, Hashimoto S, Akishita M, Ogawa S. The roles of sex hormones in the pathophysiology of age-related sarcopenia and frailty. Reprod Med Biol. 2024, 23:e12569. 10.1002\/rmb2.12569","journal-title":"Reprod Med Biol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2017.1362389","article-title":"Emerging anabolic agents in the treatment of osteoporosis","volume":"22","author":"Lovato C","year":"2017","unstructured":"Lovato C, Lewiecki EM. Emerging anabolic agents in the treatment of osteoporosis. Expert Opin Emerg Drugs. 2017, 22:247-57. 10.1080\/14728214.2017.1362389","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.838526","article-title":"Anabolic-androgenic steroids and exercise training: breaking the myths and dealing with better outcome in sarcopenia","volume":"13","author":"Falqueto H","year":"2022","unstructured":"Falqueto H, Dos Santos MR, Manfredi LH. Anabolic-androgenic steroids and exercise training: breaking the myths and dealing with better outcome in sarcopenia. Front Physiol. 2022, 13:838526. 10.3389\/fphys.2022.838526","journal-title":"Front Physiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.9734\/JAMMR\/2023\/v35i205179","article-title":"Lean body mass in osteoporotic postmenopausal women treated with nandrolone decanoate: a systematic search review","volume":"35","author":"C\u00e2mara LC","year":"2023","unstructured":"C\u00e2mara LC, Starling MA, Canvilo LM, Civile V, Mo\u00e7a VF. Lean body mass in osteoporotic postmenopausal women treated with nandrolone decanoate: a systematic search review. J Adv Med Med Res. 2023, 35:105-13. 10.9734\/JAMMR\/2023\/v35i205179","journal-title":"J Adv Med Med Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56110606","article-title":"Nandrolone decanoate: use, abuse and side effects","volume":"56","author":"Patan\u00e8 FG","year":"2020","unstructured":"Patan\u00e8 FG, Liberto A, Maria Maglitto AN, et al.. Nandrolone decanoate: use, abuse and side effects. Medicina (Kaunas). 2020, 56:10.3390\/medicina56110606","journal-title":"Medicina (Kaunas)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.180001","article-title":"Testosterone and sarcopenia","volume":"36","author":"Shin MJ","year":"2018","unstructured":"Shin MJ, Jeon YK, Kim IJ. Testosterone and sarcopenia. World J Mens Health. 2018, 36:192-8. 10.5534\/wjmh.180001","journal-title":"World J Mens Health"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(89)90027-3","article-title":"Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal","volume":"11","author":"Hassager C","year":"1989","unstructured":"Hassager C, Riis BJ, P\u00f8denphant J, Christiansen C. Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal. Maturitas. 1989, 11:305-17. 10.1016\/0378-5122(89)90027-3","journal-title":"Maturitas"},{"key":"ref29","article-title":"[Effect of anabolic steroids on osteoporosis]","volume":"18","author":"Adachi M","year":"2008","unstructured":"Adachi M, Takayanagi R. [Effect of anabolic steroids on osteoporosis]. Clin Calcium. 2008, 18:1451-9.","journal-title":"Clin Calcium"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/278374-investigating-the-role-of-nandrolone-decanoate-in-the-management-of-osteosarcopenia-in-postmenopausal-women-a-prospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T09:50:18Z","timestamp":1748080218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/278374-investigating-the-role-of-nandrolone-decanoate-in-the-management-of-osteosarcopenia-in-postmenopausal-women-a-prospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.84726","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,24]]}}}